Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

about

New treatment paradigms for ADPKD: moving towards precision medicine.Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.

P2860

Q49494721-DC706857-B4CF-47D8-B9A3-DA92A1D5ACDC Q49855458-D2B1FFA3-534F-4BC6-8EFE-9C8992124D1D

P2860

Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

Item

http://www.wikidata.org/entity/Q41003622

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Renal hemodynamic effects of t ...... ant polycystic kidney disease.

@en

type

Item

label

Renal hemodynamic effects of t ...... ant polycystic kidney disease.

@en

prefLabel

Renal hemodynamic effects of t ...... ant polycystic kidney disease.

@en

P1476

Renal hemodynamic effects of t ...... ant polycystic kidney disease.

@en

P2093

Andrea Angioi

http://www.w3.org/2001/XMLSchema#string

Bernard F King

http://www.w3.org/2001/XMLSchema#string

Eric J Bergstralh

http://www.w3.org/2001/XMLSchema#string

Fernando C Fervenza

http://www.w3.org/2001/XMLSchema#string

Ladan Zand

http://www.w3.org/2001/XMLSchema#string

Sanjeev Sethi

http://www.w3.org/2001/XMLSchema#string

Timothy S Larson

http://www.w3.org/2001/XMLSchema#string

Vicente E Torres

http://www.w3.org/2001/XMLSchema#string

P2860

Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades

Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering

Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.

Polycystic kidney disease.

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors.

Endothelial dysfunction and oxidative stress in polycystic kidney disease.

Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.

Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.

Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone.

P304

1290-1295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFV394

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284903922

http://www.w3.org/2001/XMLSchema#string

P698

26614268

http://www.w3.org/2001/XMLSchema#string

P921

autosomal dominant polycystic kidney disease

hemodynamics

P932

5009420

http://www.w3.org/2001/XMLSchema#string

Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

about

P2860

P2860

Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932